Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

E-ISSN： 1873-4294|6|8|771-785

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.8, 2006-04, pp. : 771-785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1580-1592

Bentham Science Publishers

Access to resources Recommend Favorite

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

By Singh Surendra P. Singh Vidhi

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 859-885

Adis International

Access to resources Recommend Favorite

NMDA Pathology and Treatment of Schizophrenia

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5118-5126

Bentham Science Publishers

Access to resources Recommend Favorite

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

By Coyle Joseph Tsai Guochuan

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

NAAG, NMDA Receptor and Psychosis

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1360-1364

Bentham Science Publishers

Access to resources Recommend Favorite